Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A B-lymphoblastic leukemia/lymphoma that is characterized by the presence of lymphoblasts that carry a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein.
No clinical trials have been registered for B-lymphoblastic leukemia/lymphoma with ETV6-RUNX1.
5 publications have been identified in PubMed for B-lymphoblastic leukemia/lymphoma with ETV6-RUNX1. Research spans Case Report / Case Series (40%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (20%).
Koduru P (2025). [PMID: 39983666](https://pubmed.ncbi.nlm.nih.gov/39983666/). *Cancer Genet*. [Case Report / Case Series]
Huang X (2025). [PMID: 40066544](https://pubmed.ncbi.nlm.nih.gov/40066544/). *Clin Lab*. [Basic Science / Preclinical]
Wu W (2025). [PMID: 40089289](https://pubmed.ncbi.nlm.nih.gov/40089289/). *Ann Clin Lab Sci*. [Case Report / Case Series]
Yan YC (2024). [PMID: 39231779](https://pubmed.ncbi.nlm.nih.gov/39231779/). *Zhonghua Xue Ye Xue Za Zhi*. [Review / Meta-Analysis]
Kovach AE (2024). [PMID: 38637852](https://pubmed.ncbi.nlm.nih.gov/38637852/). *Pediatr Blood Cancer*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:33 AM UTC
Common questions about B-lymphoblastic leukemia/lymphoma with ETV6-RUNX1